Navigation Links
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
Date:4/10/2009

antiepileptic drug and will address significant unmet medical needs for patients with epilepsy. We are very excited about the future prospects for Marinus."

About Ganaxolone

Ganaxolone is a synthetic neurosteroid and derivative of the naturally occurring neuromodulator, allopregnanolone. It is being investigated as a first in class treatment for epilepsy. Ganaxolone has been administered to more than 950 healthy adult volunteers and patients in more than 35 Phase 1 and Phase 2 studies. Early epilepsy studies involved more than 100 patients and generated data supportive of the efficacy and safety of ganaxolone in the treatment of both children and adults suffering from refractory forms of epilepsy (patients who continue to have seizures despite taking multiple anticonvulsant drugs).

Marinus has successfully developed several proprietary formulations of ganaxolone.

About Marinus Pharmaceuticals

Marinus Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus Pharmaceuticals is located in Branford, Conn. Its investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. For additional information, please visit the Company's Web site at http://www.marinuspharma.com/XQUOT;" target="_new">www.marinuspharma.com.

About Domain Associates

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA. Domain's three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices
'/>"/>

SOURCE Marinus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
2. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
3. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
4. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
5. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
6. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
7. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
8. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
9. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
10. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
11. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... July 24, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... of notice on July 18, 2014 from the ... accepted the CorMedix plan to regain compliance with ... result, the NYSE-MKT is continuing the Company,s listing ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... ends the second quarter with more than $535 million in cash ... EDT at ... http://www.isispharm.com , CARLSBAD, Calif., Aug. 7 Isis,Pharmaceuticals, Inc. ... ended June 30, 2008. The Company ended the quarter,in the strongest financial ...
... /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a,company focused ... of diseases and personalized health management, today reported,operational ... year to date,ended June 30, 2008., "The ... blood,test to assess a patient,s current risk of ...
... CHAMPAIGN, Ill. By combining stretchable optoelectronics and ... imaging device, with a layout based on the ... issue of the journal Nature, researchers ... have developed a high-performance, hemispherical "eye" camera using ...
Cached Biology Technology:Isis Reports Financial Results and Highlights for Second Quarter of 2008 2Isis Reports Financial Results and Highlights for Second Quarter of 2008 3Isis Reports Financial Results and Highlights for Second Quarter of 2008 4Isis Reports Financial Results and Highlights for Second Quarter of 2008 5Isis Reports Financial Results and Highlights for Second Quarter of 2008 6Isis Reports Financial Results and Highlights for Second Quarter of 2008 7Isis Reports Financial Results and Highlights for Second Quarter of 2008 8Isis Reports Financial Results and Highlights for Second Quarter of 2008 9Isis Reports Financial Results and Highlights for Second Quarter of 2008 10Isis Reports Financial Results and Highlights for Second Quarter of 2008 11Isis Reports Financial Results and Highlights for Second Quarter of 2008 12Isis Reports Financial Results and Highlights for Second Quarter of 2008 13Isis Reports Financial Results and Highlights for Second Quarter of 2008 14GeneNews Announces Second Quarter Results 2GeneNews Announces Second Quarter Results 3GeneNews Announces Second Quarter Results 4GeneNews Announces Second Quarter Results 5GeneNews Announces Second Quarter Results 6GeneNews Announces Second Quarter Results 7GeneNews Announces Second Quarter Results 8Stretchable silicon camera next step to artificial retina 2
(Date:7/25/2014)... that the age girls reach puberty is influenced by ,imprinted ... parent contributes the gene. This is the first evidence ... birth and details of this study were published today in ... period, known as menarche, is a marker for the timing ... onset of menses varies between girls, is an inherited trait, ...
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
(Date:7/25/2014)... Florida , July 25, 2014 ... more consumers are turning to digital technology for online ... (OTCBB: NXTD), Google Inc. (NASDAQ: GOOG ), ... (NYSE: V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6
... of scientists has, for the first time, completely characterized an ... ground-level ozone in urban areas. The team,s results indicate that ... during episodes of poor air quality (smoggy days) by as ... poses significant health hazards to people, animals and plants; is ...
... JOLLA, Calif., November 1, 2010 One of the many ... fat, which in turn supports a healthy heart. Fat tissue ... it,s also an active secretory organ that normally produces ... protects the hearts of healthy people has long been a ...
... " Environmental Pollution " details successful experiments at ... in the abiotic (non-biological) transformation and absorption of ... of these estrogen hormones by more than 80 ... implications since it could point to inexpensive treatment ...
Cached Biology News:Study improves accuracy of models for predicting ozone levels in urban areas 2Study improves accuracy of models for predicting ozone levels in urban areas 3Study improves accuracy of models for predicting ozone levels in urban areas 4Study finds fat hormone's long-sought link to heart protection 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 3
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Mycoplasma and virus tested...
... Western Protein Standards are specifically designed ... weight estimation directly on western blots. ... binding site, allowing direct visualization with ... detect your target protein on the ...
... Clone/PAD: 3F10B10. Immunogen: ... internal region of JAB1 (Jun ... Specificity: Specific for the ... (positive controls: 293T Jurkat cell ...
Biology Products: